Vision-Sciences Inc. (NASDAQ:CGNT) – Stock analysts at Roth Capital upped their FY2016 earnings estimates for Vision-Sciences in a research report issued on Thursday. Roth Capital analyst C. Lewis now forecasts that the firm will post earnings of ($0.14) per share for the year, up from their prior forecast of ($0.21). Roth Capital has a “Buy” rating on the stock. Roth Capital also issued estimates for Vision-Sciences’ Q4 2016 earnings at $0.00 EPS, Q1 2017 earnings at $0.00 EPS, Q3 2017 earnings at $0.01 EPS and FY2017 earnings at $0.02 EPS.

Separately, Zacks Investment Research lowered Vision-Sciences from a “hold” rating to a “sell” rating in a research report on Friday, August 5th.

Earnings History and Estimates for Vision-Sciences (NASDAQ:CGNT)

Shares of Vision-Sciences (NASDAQ:CGNT) opened at 2.22 on Monday. The stock’s market capitalization is $58.04 million. The firm’s 50-day moving average is $1.68 and its 200-day moving average is $1.26. Vision-Sciences has a 1-year low of $0.71 and a 1-year high of $2.30.

An institutional investor recently raised its position in Vision-Sciences stock. Amici Capital LLC boosted its stake in shares of Vision-Sciences Inc. (NASDAQ:CGNT) by 14.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,415,589 shares of the medical device company’s stock after buying an additional 180,689 shares during the period. Amici Capital LLC owned about 5.58% of Vision-Sciences worth $1,557,000 at the end of the most recent quarter. Institutional investors own 30.68% of the company’s stock.

Vision-Sciences Company Profile

Cogentix Medical, Inc, formerly Vision-Sciences, Inc, is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes, otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU).

5 Day Chart for NASDAQ:CGNT

Receive News & Stock Ratings for Vision-Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vision-Sciences Inc. and related stocks with our FREE daily email newsletter.